|
C17ORF42 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.9837000000047E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.902390E-02 |
| Normal-vs-Stage2 |
1.425040E-01 |
| Normal-vs-Stage3 |
4.66980000002337E-07 |
| Normal-vs-Stage4 |
2.969100E-04 |
| Stage1-vs-Stage2 |
9.711800E-01 |
| Stage1-vs-Stage3 |
1.484540E-03 |
| Stage1-vs-Stage4 |
5.325800E-02 |
| Stage2-vs-Stage3 |
3.199800E-02 |
| Stage2-vs-Stage4 |
1.676600E-01 |
| Stage3-vs-Stage4 |
4.367800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.66160000000448E-05 |
| Normal-vs-AfricanAmerican |
1.924770E-01 |
| Normal-vs-Asian |
5.244400E-01 |
| Caucasian-vs-AfricanAmerican |
2.232200E-01 |
| Caucasian-vs-Asian |
3.881900E-02 |
| AfricanAmerican-vs-Asian |
1.849200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.44629999982082E-07 |
| Normal-vs-Female |
2.598400E-01 |
| Male-vs-Female |
7.73130000000233E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.367700E-04 |
| Normal-vs-Age(41-60Yrs) |
3.583200E-03 |
| Normal-vs-Age(61-80Yrs) |
2.035900E-04 |
| Normal-vs-Age(81-100Yrs) |
9.385600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.551240E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.711400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.129400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.094400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.993800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.598400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.715600E-01 |
| Normal-vs-Grade 2 |
2.637900E-02 |
| Normal-vs-Grade 3 |
1.840120E-04 |
| Normal-vs-Grade 4 |
5.11709999928556E-08 |
| Grade 1-vs-Grade 2 |
6.173000E-01 |
| Grade 1-vs-Grade 3 |
2.497800E-01 |
| Grade 1-vs-Grade 4 |
1.734110E-02 |
| Grade 2-vs-Grade 3 |
1.230780E-01 |
| Grade 2-vs-Grade 4 |
4.837800E-04 |
| Grade 3-vs-Grade 4 |
7.176500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.049600E-01 |
| Normal-vs-ccB subtype |
4.42850000004213E-07 |
| ccA subtype-vs-ccB subtype |
1.03880000001944E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.259600E-02 |
| Normal-vs-N1 |
1.440070E-02 |
| N0-vs-N1 |
4.108200E-01 |
|
|
